Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 7:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 1,725 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: AIMS Clear all

Conditions: Cystitis, Interstitial, Dysmenorrhea, Migraine Disorders, Pelvic Pain, Endometriosis, Visceral Pain, Chronic Pain
Interventions: cyclic microgestin 1/20, continuous microgestin 1/20; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 353 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Dementia
Interventions: Caregiving While Black-LIVE; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Overdose
Interventions: Brief youth overdose prevention education, Usual Standard of Care; Behavioral · Other
Lead sponsor: Boston Medical Center; Other
Eligibility: 13 Years and older
Enrollment: 648 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Major Depression
Interventions: D-Cycloserine (DCS), Continuous theta-burst stimulation (cTBS), Transcranial Magnetic Stimulation Sham, Memantine, Lorazepam (drug), Baclofen, Placebo; Drug · Device
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Post Traumatic Stress Disorder
Interventions: Aim 2: BounceBack Now (BBN) for Trauma Informed Care Deployment, Aim 1 Participant Focus Groups, Aim 1 BHP Focus Groups, Aim 2: BHP, Provider, Staff and Admin Focus Groups, Aim 2 : Participant Focus Group; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 2
States / cities: Omaha, Nebraska

Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
Interventions: Educational video, Interview, Observation; Other
Lead sponsor: Emory University; Other
Eligibility: Not listed
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 2
States / cities: Atlanta, Georgia • Decatur, Georgia

Conditions: Cancer
Interventions: Embodied Conversational Agent, REDCap Survey; Behavioral
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain, Exposure, Adolescent Behavior, Child Behavior
Interventions: Graded exposure treatment (GET); Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Menlo Park, California

Conditions: Work-Related Condition
Interventions: Targeted Educational Campaign; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 21 Years and older
Enrollment: 451 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Opioid Use Disorder
Interventions: Medication for opioid use disorder, psychotherapy; Drug · Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2028 – 2030
U.S. locations: 1
States / cities: Irvine, California

Conditions: Sedentary Behavior, Hypertriglyceridemia
Interventions: Interrupting Prolonged Sitting with Periodic Interval Exercise: Effect on Postprandial Lipemia; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Acute Myeloid Leukemia/Myelodysplastic Syndrome, Multiple Myeloma (MM)
Interventions: NKR-2 cells; Biological
Lead sponsor: Celyad Oncology SA; Industry
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 2
States / cities: Tampa, Florida • Buffalo, New York

Conditions: Alzheimer Disease and Related Dementias, Dementia Alzheimers
Interventions: MASC; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Stroke
Interventions: Passive stretching, Passive movement, IntelliArm, Hand robot; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 85 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hypertension, HIV-1-infection
Interventions: Hypertension control through education and monitoring; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Depression, Epilepsy
Interventions: sertraline, cognitive behavior therapy; Drug · Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 21 Years to 75 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2008
U.S. locations: 2
States / cities: St Louis, Missouri • New York, New York

Conditions: Stroke
Interventions: IMT Robotic Arm therapy; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Huntington Disease, Parkinson Disease
Interventions: MindTrails; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 21 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Metabolism and Nutrition Disorder, Obesity
Interventions: NNC9204-1177, Placebo; Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 55 Years · Male only
Enrollment: 49 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer
Interventions: Just ASK training; Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Plainsboro, New Jersey

Conditions: Neck Pain, Sleep Disturbance
Interventions: Dry Needling, Therapeutic Exercise; Procedure · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 75 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Physical Inactivity, Overweight and Obesity
Interventions: Prevent T2, Move group-based classes, Fitness Membership, Mental Imagery, Move 1:1 Support; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 65 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Knoxville, Tennessee

Conditions: Heart Failure, Diuretic Resistance
Interventions: Ammonium Chloride, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Breast Cancer, Biliary Tract Carcinoma, Ovarian Cancer, Endometrial Cancer, Squamous Non-Small Cell Lung Cancer
Interventions: AZD8205, AZD8205 and AZD2936 (Rilvegostomig), AZD8205 and AZD5305 (saruparib), AZD8205 and AZD5305 (saruparib) and AZD2936 (rilvegostomig), AZD8205 in combination with AZD9574, AZD8205 in combination with AZD9574 plus rilvegostomig (AZD2936); Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 14
States / cities: Duarte, California • Irvine, California • Santa Monica, California + 11 more

Search by objective public record fields.

Chronic Pain Risk Associated With Menstrual Period Pain

Caregiving While Black: LIVE

A Universal Primary Care Based Intervention to Reduce Youth Overdose Risk Aim 3

Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression

Using Mobile Technology to Address the Trauma Mental Health Treatment Gap

Communication Issues in Patient and Provider Discussions of Immunotherapy

Improving PRO for Patients With Cancer Using ECAs and Data Visualization

Agile Development of a Digital Exposure Treatment for Youth With Chronic Musculoskeletal Pain

Survey of Correction Officers Before and After a Targeted Education Campaign

Dynamic Treatment Regimes for Opioid Use Disorder

Interrupting Prolonged Sitting With Periodic Interval Exercise: Effect on Postprandial Lipemia

A Dose Escalation Phase I Study to Assess the Safety and Clinical Activity of Multiple Cancer Indications

MASC: Reducing Stress for Caregivers

Robot Aided Rehabilitation - Intervention

Addressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression

Depression and Health Outcomes in Refractory Epilepsy

The General Use of Robots in Stroke Recovery

Measurement and Modification of Threat Interpretation Bias in Neurodegenerative Movement Disorders (Aims 2 & 3)

A First Human Dose Trial Investigating Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-1177 in Subjects Being Overweight or With Obesity.

A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials

Dry Needling and Therapeutic Exercise on Sleep in Individuals With Chronic Neck Pain and Sleep Disturbance

A Pilot Factorial Trial of an Integrated Lifestyle Intervention

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies